Evercore Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Evercore Wealth Management, LLC

$6.66 Billion
Q3 2024

A detailed history of Evercore Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Evercore Wealth Management, LLC holds 1,873 shares of VRTX stock, worth $870,120. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,873

Previous 1,873 -0.0%

Holding current value

$870,120

Previous $877,000 0.68%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $4,892 - $5,352	12 Added 0.64%	1,873 $782,000
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $47,677 - $57,084	139 Added 8.07%	1,861 $757,000
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $676 - $724	2 Added 0.12%	1,722 $598,000
Q2 2023 Aug 04, 2023	BUY	$314.42 - $351.91 $5,973 - $6,686	19 Added 1.12%	1,720 $605,000
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $6,231 - $7,108	22 Added 1.31%	1,701 $535,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $10,001 - $11,251	35 Added 2.13%	1,679 $484,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $13,691 - $15,276	50 Added 3.14%	1,644 $476,000
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $6,199 - $7,307	-28 Reduced 1.73%	1,594 $416,000
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $5,487 - $6,926	-31 Reduced 1.88%	1,622 $356,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $725 - $811	4 Added 0.24%	1,653 $300,000
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $51,747 - $61,023	-276 Reduced 14.34%	1,649 $332,000
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $93,366 - $108,830	-451 Reduced 18.98%	1,925 $414,000
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $5,175 - $6,902	-25 Reduced 1.04%	2,376 $562,000
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $15,850 - $18,792	62 Added 2.65%	2,401 $653,000
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $15,332 - $20,114	-68 Reduced 2.83%	2,339 $679,000
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $87,898 - $109,036	440 Added 22.37%	2,407 $573,000
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $9,169 - $12,315	55 Added 2.88%	1,967 $431,000
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $1,662 - $1,870	10 Added 0.53%	1,912 $324,000
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $5,102 - $5,901	31 Added 1.66%	1,902 $349,000
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $6,876 - $8,177	42 Added 2.3%	1,871 $344,000
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $3,493 - $4,420	-23 Reduced 1.24%	1,829 $303,000
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $46,628 - $53,581	-278 Reduced 13.05%	1,852 $357,000
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $29,144 - $33,992	-200 Reduced 8.58%	2,130 $362,000
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $60,640 - $70,852	-400 Reduced 14.65%	2,330 $380,000
Q4 2017 Feb 13, 2018	SELL	$137.28 - $155.55 $44,616 - $50,553	-325 Reduced 10.64%	2,730 $409,000
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $452,537 - $495,643	3,055	3,055 $464,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.

Account

Evercore Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History